Coming Up On US FDA’s User Fee Calendar: Zynteglo Approval Kicks Off Busy Season For Advanced Biologics, Pediatrics

 
• By Bridget Silverman

At least 17 applications are pending with late August and September 2022 user fee goal dates, the Pink Sheet US FDA Performance Tracker shows.

Stem cells
Is the FDA's approval of a new stem cell treatment a harbinger of more approvals in the coming weeks? • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers